Postpartum depression
Postpartum depression (PPD) is a major depressive episode with peripartum onset — beginning during pregnancy or in the year following delivery. It affects approximately 15-20% of pregnant and postpartum people and is highly treatable with psychotherapy, medication, and integrated support.
Overview
Postpartum depression (PPD) is the lay term for what the DSM-5-TR classifies as Major Depressive Disorder, with peripartum onset (296.2x or 296.3x with specifier). The DSM-5-TR defines peripartum onset as “during pregnancy or in the four weeks following delivery”; clinical practice generally extends the perinatal mental-health window through the first year postpartum to capture clinically relevant cases that emerge later in the postpartum period.
PPD affects approximately 15-20% of pregnant and postpartum people. Despite its high prevalence, it is significantly under-recognized: approximately 50% of cases are not detected in routine perinatal care. Stigma, normalization of postpartum distress as “baby blues,” and reluctance to disclose all contribute. The Canadian Paediatric Society, Society of Obstetricians and Gynaecologists, and other professional bodies recommend routine PPD screening.
PPD is distinct from “baby blues” — a brief (1-2 week) period of mood lability, tearfulness, and emotional sensitivity affecting approximately 80% of new mothers, peaking around days 3-5 postpartum, resolving without treatment. PPD is more severe, persists beyond 2 weeks, and meets diagnostic criteria for major depressive disorder.
Common PPD presentations include: persistent low mood, anhedonia, sleep difficulties beyond newborn-related, appetite changes, fatigue, guilt (often focused on parenting), hopelessness, difficulty bonding with the baby, intrusive thoughts (often baby-related), and in severe cases, suicidal ideation or thoughts of harming the baby. Postpartum depression with mixed features, anxious distress, or psychotic features warrants particularly close attention.
PPD is highly comorbid with perinatal anxiety, perinatal OCD, and postpartum PTSD. It also requires careful differentiation from postpartum psychosis (a psychiatric emergency, 1-2 per 1,000 cases) and from bipolar disorder (peripartum onset substantially elevates bipolar risk; antidepressant monotherapy in unrecognized bipolar can precipitate switches).
Treatment is highly effective. Evidence-based psychotherapies (Interpersonal Therapy is particularly well-studied for PPD), pharmacotherapy (sertraline has the most extensive perinatal safety data; brexanolone and zuranolone are FDA-approved specifically for PPD), and integrated support all produce meaningful improvement. PPD is treatable; help-seeking saves lives.
Signs and symptoms
- Persistent low mood or sadness — Sustained sad, empty, or hopeless mood most of the day, more days than not, lasting more than 2 weeks.
- Anhedonia — Markedly diminished interest or pleasure in most activities, including activities that previously brought joy and including baby care.
- Sleep changes beyond newborn-related — Inability to sleep when baby sleeps; sleeping excessively when given the chance; non-restorative sleep distinct from typical postpartum sleep deprivation.
- Appetite and weight changes — Significant change in appetite or weight in either direction.
- Fatigue beyond newborn-related — Profound exhaustion not explained by baby care; difficulty mobilizing for tasks.
- Guilt and worthlessness — Persistent guilt — often focused on parenting performance, comparison to other parents, sense of failure as a mother/parent.
- Difficulty bonding with baby — Difficulty feeling love, connection, or attachment to baby; emotional numbing; sense of being a "bad mother" for not feeling differently.
- Intrusive thoughts — Distressing intrusive thoughts about baby — often about accidental harm. Common in postpartum OCD and frequently distressing precisely because they conflict with parental love.
- Concentration difficulties — Impaired concentration, decision-making, indecisiveness — beyond typical "mommy brain."
- Suicidal thoughts — Thoughts of death, suicide, or thoughts of harming the baby. Suicide is a leading cause of maternal mortality. Any suicidal ideation in PPD warrants immediate evaluation.
Diagnostic context
The DSM-5-TR criteria for Major Depressive Disorder, with peripartum onset (296.2x or 296.3x with specifier) require:
- A. 5+ of 9 symptoms (including either depressed mood or anhedonia) most of the day, nearly every day, for at least 2 weeks.
- B. Clinically significant distress or impairment.
- C. Not attributable to substance or medical condition.
- D. Not better explained by other psychotic disorders.
- E. No history of manic or hypomanic episodes (would change diagnosis to bipolar disorder).
- Specifier: with peripartum onset — symptoms began during pregnancy or in the 4 weeks following delivery (clinical practice extends to first year postpartum).
Differential diagnosis includes:
- Baby blues — brief, self-limiting, not clinically significant.
- Perinatal anxiety disorders — generalized anxiety, panic, OCD; frequently comorbid.
- Postpartum PTSD — when birth was traumatic.
- Bipolar disorder with peripartum onset — important to assess for past hypomania/mania; antidepressant monotherapy in unrecognized bipolar can precipitate switches.
- Postpartum psychosis — psychiatric emergency with hallucinations, delusions, severe confusion; requires immediate evaluation.
- Thyroid dysfunction — postpartum thyroiditis is common and can present with depressive symptoms.
- Substance/medication-induced mood disorders.
Validated screening instruments include the Edinburgh Postnatal Depression Scale (EPDS — most widely used), Patient Health Questionnaire (PHQ-9), and Postpartum Depression Screening Scale.
Causes and risk factors
PPD develops through interaction of biological, psychological, and social factors:
Biological factors: rapid hormonal changes after delivery (particularly steep drop in estrogen and progesterone), sleep deprivation, thyroid dysfunction (postpartum thyroiditis common), genetic vulnerability, prior history of depression.
Pre-existing mental-health: personal history of depression, anxiety, bipolar disorder, OCD, or other mental-health conditions substantially elevates PPD risk. Approximately 50-70% of PPD cases occur in people with prior mental-health history.
Pregnancy and birth factors: infertility, pregnancy loss, prior PPD, complications, traumatic birth, NICU admission, premature delivery, breastfeeding difficulties, baby health concerns all elevate risk.
Psychosocial factors: partner support quality, social support, financial stability, immigration status (with isolation), language barriers, family history, history of childhood adversity, history of trauma (particularly sexual trauma which often resurfaces in pregnancy and birth).
Social factors: social isolation, housing instability, intimate partner violence (active or recent), unplanned pregnancy, single parenting without adequate support.
Cultural factors: cultural norms around postpartum support, immigration-related disconnection from cultural support systems, varying cultural recognition of perinatal depression.
Comorbidity: perinatal anxiety (~50% of PPD has comorbid anxiety), postpartum OCD, postpartum PTSD, substance use, eating disorders all common comorbidities.
Typical treatments
Evidence-based PPD treatment includes:
Psychotherapy:
- Interpersonal Therapy (IPT) — strongest evidence base for PPD. Brief 12-16 session protocol focused on interpersonal precipitants and consequences.
- Cognitive behavioural Therapy — strong evidence; addresses cognitive patterns and behavioural activation.
- Mindfulness-Based Cognitive Therapy — particularly for relapse prevention.
- Trauma-focused therapies when birth trauma or pre-existing trauma is part of the picture.
Pharmacotherapy:
- SSRIs — first-line. Sertraline has the most extensive perinatal safety data and is generally first choice. Fluoxetine, citalopram, escitalopram also commonly used. Paroxetine generally avoided in pregnancy due to safety concerns.
- SNRIs — venlafaxine is sometimes used.
- Brexanolone (Zulresso) — FDA-approved 2019 specifically for PPD; IV infusion.
- Zuranolone (Zurzuvae) — FDA-approved 2023, oral medication for PPD; rapid onset.
- Untreated PPD carries substantial risks for both parent and baby — risk-benefit analysis should not assume that no medication is automatically safer.
- Most psychiatric medications are compatible with breastfeeding; coordinate with prescriber and lactation consultant.
Combined treatment (psychotherapy + pharmacotherapy) outperforms either alone for moderate-to-severe PPD.
Group therapy and peer support: postpartum mood disorder support groups, doula support, perinatal peer support — reduce isolation and provide normalization.
Partner involvement: partner education, partner mental-health screening (paternal/non-birthing-parent PPD affects ~10% of partners), couples support.
Sleep support: structured sleep planning is therapeutically important; sleep deprivation is a major contributor to PPD severity.
Specialized perinatal services: many Canadian provinces have specialized perinatal mental-health programs (BC Reproductive Mental Health, Alberta Health Services Reproductive Mental Health Program, others).
For postpartum psychosis: psychiatric emergency requiring immediate evaluation, often hospitalization, antipsychotic and mood stabilizer medication. ECT for severe cases.
When to seek help
Professional support is indicated when:
- You are pregnant or in the first year postpartum and experiencing persistent low mood, anxiety, or significant sleep difficulties beyond newborn-related.
- You are having difficulty bonding with your baby.
- You are experiencing intrusive thoughts about your baby — particularly thoughts of accidental or intentional harm.
- You feel hopeless, worthless, or like a failure as a parent.
- You have suicidal thoughts or thoughts of harming yourself or your baby.
- You have a history of depression, anxiety, bipolar disorder, or other mental-health conditions.
- Your partner or family members have expressed concern about changes they have noticed.
- You experienced a difficult or traumatic birth and are having lasting impact.
Postpartum psychosis is a psychiatric emergency. Symptoms include rapid mood changes, hallucinations, delusions, severe confusion, or thoughts of harming self or baby. Immediate evaluation is required — contact emergency services (911) or the nearest emergency department.
Free 24-hour Canadian perinatal mental-health support:
- 1-800-944-4773 — Postpartum Support International (PSI) Helpline; text “Help” to 800-944-4773 in English or “Hablar” for Spanish.
- 9-8-8 — Suicide Crisis Helpline, call or text, 24/7.
- 1-833-456-4566 — Talk Suicide Canada, 24/7.
- 1-800-668-6868 — Kids Help Phone (for parents under 20).
- 1-855-242-3310 — Hope for Wellness Helpline (Indigenous-led, 24/7).
- 811 — Health Link (provincial non-emergency line).
- Provincial perinatal mental-health programs in BC, Alberta, Ontario, Quebec, and other provinces.
Frequently asked questions
How is PPD different from baby blues?
Can dads or non-birthing partners get PPD?
I have intrusive thoughts about hurting my baby — am I dangerous?
Is medication safe during breastfeeding?
When should I worry about postpartum psychosis?
Will PPD go away on its own?
References
- American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). APA.
- Postpartum Support International. (n.d.). Resources and helpline.
- O'Hara, M. W., & McCabe, J. E. (2013). Postpartum depression: Current status and future directions. Annual Review of Clinical Psychology, 9, 379–407.
- Wisner, K. L., et al. (2013). Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry, 70(5), 490–498.
- Society of Obstetricians and Gynaecologists of Canada. (n.d.). Perinatal mental health resources.
Find a Therapist by City
Browse therapy availability by city to see local and virtual options, explore services, and connect with a clinician who can serve your area.
Find a Therapist by Province
Browse therapy options by province to see which clinicians are available to work with clients in your region.
Trusted by Leading Psychology & Mental Health Organizations Across Canada
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Trusted By Alberta’s Leading Psychology & Mental Health Organizations
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Alberta and Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Regulated and affiliated across Alberta’s leading psychology, counselling, and mental-health organizations.
Regulated and affiliated across Canada’s leading psychology, counselling, and mental-health organizations.
